Chairman of the Board International Myeloma Foundation (IMF);
The International Myeloma Working Group (IMWG);
Black Swan Research Initiative (BSRI)
Co-chair of Myeloma Committee
Southwest Oncology Group (SWOG)
Director of Myeloma Research
AMyC Clinical Trials Consortium
8700 Beverly Boulevard
Los Angeles, CA 90048
IMF Assistant, Xuan Lam
Dr. Durie is the Chairman of the Board of the International Myeloma Foundation as well as Chairman of the IMWG and BSRI project. Dr. Durie is also the Medical Director of Myeloma Research for the Academic Myeloma (AMyC) Consortium and Co-chairman of the myeloma committee for SWOG. Dr. Durie, along with Dr. Sydney Salmon, co-created the Durie/Salmon Staging System, which is used worldwide for evaluating patients with myeloma.
In addition, Dr. Durie is a specialist in multiple myeloma and related disorders at the Cedars-Sinai Medical Center, with offices located in the Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute in Los Angeles. Previously, he was a professor at the University of Arizona, College of Medicine, and the Charing Cross and Westminster School of Medicine at the University of London.
He is the recipient of numerous honors and awards for excellence. He is a Leukemia Society of America Scholar and a U.S. Hematologic Research Foundation Annual Awardee. Dr. Durie received the 2006 Robert A. Kyle Lifetime Achievement Award, which honors a physician who most exemplifies singular dedication to and compassion for myeloma patients in the search for the best treatment for myeloma. In 2009, Dr. Durie also received the Waldenström’s Award in recognition of his contributions to the field of multiple myeloma research.
Dr. Durie has written over 600 research papers, sixteen book chapters, and five books. He is also an international patent holder for scintillation autoradiography.
Dr. Durie received his medical degree from the University of Edinburgh Medical School, Scotland. He completed residencies and fellowships at Mayo Clinic and the University of Minnesota. He is board certified by the American Board of Internal Medicine with subspecialties in both medical oncology and hematology.